Evidence map›Paper›PMID 37641572›Full record

ReviewFASEB journal : official publication of the Federation of American Societies for Experimental Biology2023

Endometriosis in the era of precision medicine and impact on sexual and reproductive health across the lifespan and in diverse populations.

Linda C Giudice, Tomiko T Oskotsky, Simileoluwa Falako, Jessica Opoku-Anane, Marina Sirota

Open access · hybridAbstract readReview
In one paragraph

Review in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 3 pooled it
21.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 3 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Observational
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. The Impact of Endometriosis on Ovarian Reserve: A Systematic Review.International journal of women's health · 2026
    Review
  15. Review
  16. Endometriosis: From Genes to Global Burden.International journal of molecular sciences · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Linda C GiudiceUCSF Stanford Endometriosis Center for Innovation, Training, and Community Outreach (ENACT), University of California, San Francisco, San Francisco, California, USA.ORCID 0000-0002-1677-0822
Tomiko T OskotskyUCSF Stanford Endometriosis Center for Innovation, Training, and Community Outreach (ENACT), University of California, San Francisco, San Francisco, California, USA.ORCID 0000-0001-7393-5120
Simileoluwa FalakoUCSF Stanford Endometriosis Center for Innovation, Training, and Community Outreach (ENACT), University of California, San Francisco, San Francisco, California, USA.ORCID 0000-0003-1697-390X
Jessica Opoku-AnaneUCSF Stanford Endometriosis Center for Innovation, Training, and Community Outreach (ENACT), University of California, San Francisco, San Francisco, California, USA.ORCID 0000-0003-2252-1571
Marina SirotaUCSF Stanford Endometriosis Center for Innovation, Training, and Community Outreach (ENACT), University of California, San Francisco, San Francisco, California, USA.ORCID 0000-0002-7246-6083
University of California, San Francisco · USGynecologic Oncology Group · US

Funding

UCSF Stanford Endometriosis Center for Discovery, Innovation, Training and Community EngagementP01HD106414 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI OPOKU-ANANE, JESSICA · 2021 to 2025
$7.1M
NICHD NIH HHS P01 HD106414
6 · The paper itself

Abstract

Endometriosis is a common estrogen-dependent disorder wherein uterine lining tissue (endometrium) is found mainly in the pelvis where it causes inflammation, chronic pelvic pain, pain with intercourse and menses, and infertility. Recent evidence also supports a systemic inflammatory component that underlies associated co-morbidities, e.g., migraines and cardiovascular and autoimmune diseases. Genetics and environment contribute significantly to disease risk, and with the explosion of omics technologies, underlying mechanisms of symptoms are increasingly being elucidated, although novel and effective therapeutics for pain and infertility have lagged behind these advances. Moreover, there are stark disparities in diagnosis, access to care, and treatment among persons of color and transgender/nonbinary identity, socioeconomically disadvantaged populations, and adolescents, and a disturbing low awareness among health care providers, policymakers, and the lay public about endometriosis, which, if left undiagnosed and under-treated can lead to significant fibrosis, infertility, depression, and markedly diminished quality of life. This review summarizes endometriosis epidemiology, compelling evidence for its pathogenesis, mechanisms underlying its pathophysiology in the age of precision medicine, recent biomarker discovery, novel therapeutic approaches, and issues around reproductive justice for marginalized populations with this disorder spanning the past 100 years. As we enter the next revolution in health care and biomedical research, with rich molecular and clinical datasets, single-cell omics, and population-level data, endometriosis is well positioned to benefit from data-driven research leveraging computational and artificial intelligence approaches integrating data and predicting disease risk, diagnosis, response to medical and surgical therapies, and prognosis for recurrence.

Indexed as

Chronic PainEndometriosisAdolescentAged, 80 and overArtificial IntelligenceFemaleHumansLongevityPrecision MedicineQuality of LifeReproductive Healthaccessbiomarkersdiagnosisdiversityendometriosisequityhealth disparitiesprecision medicinetherapies

Identifiers

PMID37641572
PMCPMC10503213
OpenAlexW4386255695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.